EUVIMEDObjevte EUVIMED
FallberichtOpen access · CC BY-NC-ND 4.0

Situational prevention: Pharmacotherapy during periods of increased risk for migraine attacks

Richard B Lipton iD, Jessica Ailani, Kathleen Mullin iD, Jelena M Pavlovic, Stewart J Tepper, David W Dodick, Andrew M Blumenfeld

Headache: The Journal of Head and Face Pain · 2024-07 · 64 (7) · 859-864

DOI: 10.1111/head.14775 ↗

At a glance

Fallbericht in Headache: The Journal of Head and Face Pain, published online on 2024-07-03. Written by Richard B Lipton and 6 co-authors. Institution: Department of Neurology, Albert Einstein College of Medicine, Bronx, New York, USA. Major MEDLINE topics: Migraine Disorders, Calcitonin Gene-Related Peptide Receptor Antagonists. Cited 16 times so far (Crossref); 9 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Pfizer, Inc, Pfizer.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

The small molecule calcitonin gene–related peptide receptor antagonists (gepants) are the only drug class with medicines indicated for both the acute and preventive treatment of migraine. Given this dual capacity to both treat and prevent, along with their favorable tolerability profiles and lack of an association with medication‐overuse headache, headache specialists have begun to use gepants in ways that transcend the traditional categories of acute and preventive treatment. One approach, called situational prevention , directs patients to treat during the interictal phase, before symptoms develop, in situations of increased risk for migraine attacks. Herein, we present three patients to illustrate scenarios of gepant use for situational prevention. In each case, a gepant was started in anticipation of a period of increased headache probability (vulnerability) and continued for a duration of 1 day to 5 consecutive days. Although this approach may expose patients to medication when headache may not have developed, the tolerability and safety profile and preventive effect of gepants may represent a feasible approach for some patients. Situational prevention is an emerging strategy for managing migraine before symptoms develop in individuals who can identify periods when the probability of headache is high. This paper is intended to increase awareness of this strategy and stimulate future randomized, placebo‐controlled trials to rigorously assess this strategy.

Subjects

MeSH terms (MEDLINE)

Migraine DisordersCalcitonin Gene-Related Peptide Receptor AntagonistsHumansFemaleAdultMaleMiddle Aged

Author keywords

acutegepantinterictalmigrainepreventivesituational prevention

Substances

Calcitonin Gene-Related Peptide Receptor Antagonists

Authors and institutions

  • Department of Neurology, Albert Einstein College of Medicine, Bronx, New York, USA.
  • Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York, USA.
  • Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, Bronx, New York, USA.
  • Department of Neurology, Medstar Georgetown University Hospital, Washington, DC, USA.
  • The New England Institute for Neurology and Headache, Stamford, Connecticut, USA.
  • Department of Neurology, Mayo Clinic, Scottsdale, Arizona, USA.

ORCID profiles: Richard B Lipton, Kathleen Mullin

Funding

  • Pfizer, Inc
  • Pfizer

Cite

APA

Lipton, R. B., Ailani, J., Mullin, K., Pavlovic, J. M., Tepper, S. J., Dodick, D. W., & Blumenfeld, A. M. (2024). Situational prevention: Pharmacotherapy during periods of increased risk for migraine attacks. Headache: The Journal of Head and Face Pain, 64(7), 859-864. https://doi.org/10.1111/head.14775

Vancouver

Lipton RB, Ailani J, Mullin K, Pavlovic JM, Tepper SJ, Dodick DW, et al. Situational prevention: Pharmacotherapy during periods of increased risk for migraine attacks. Headache: The Journal of Head and Face Pain. 2024;64(7):859-864. doi:10.1111/head.14775

BibTeX
@article{Lipton2024,
  author = {Lipton, Richard B and Ailani, Jessica and Mullin, Kathleen and Pavlovic, Jelena M and Tepper, Stewart J and Dodick, David W and Blumenfeld, Andrew M},
  title = {Situational prevention: Pharmacotherapy during periods of increased risk for migraine attacks},
  journal = {Headache: The Journal of Head and Face Pain},
  year = {2024},
  volume = {64},
  number = {7},
  pages = {859--864},
  doi = {10.1111/head.14775}
}
Start for free →